Hosted on MSN1d
Purple Biotech advances NT219 into Phase II recurrent/metastatic SCCHN study
Purple Biotech has entered a Phase II trial with its small molecule drug, NT219, focusing on patients with ...
Six early warning signs of skin cancer you should never ignore as Danielle Lloyd announces shock diagnosis
BRITS have been urged to look out for SIX early warning signs of skin cancer you should never ignore as Danielle Lloyd ...